Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028


  • Rep Id : XPLREP3664
  • Published On : January, 2019
  • No. of Pages : 193
  • Category : Healthcare
  • Publisher : Future Market Insights

A recent market study published by the company titled, 'Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028', consists of a comprehensive assessment of the most important market dynamics of this market. On conducting a thorough research on the historic as well as current growth parameters of the psoriatic arthritis (PsA) treatment market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the psoriatic arthritis (PsA) treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies in order to envisage maximum growth in the psoriatic arthritis (PsA) treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the psoriatic arthritis (PsA) treatment market in the most comprehensive way for the better understanding of readers.

Chapter 01 – Executive Summary

The report commences with the executive summary of the psoriatic arthritis (PsA) treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments in the psoriatic arthritis (PsA) treatment market.

Chapter 02 – Market Overview

Readers can find a detailed taxonomy and the definition of the psoriatic arthritis (PsA) treatment market in this chapter, which will help them better understand the basic information about the psoriatic arthritis (PsA) treatment market dynamics, clinical trials, average cost of treatment, and key regulations that have been included in the report.

Chapter 03 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Product Type

Based on product type, the psoriatic arthritis (PsA) treatment market is segmented into nonsteroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, and biologics. Disease modifying antirheumatic drugs are further sub-segmented into corticosteroids, antimalarial, methotrexate, and others. Biologics are further sub-segmented into TNF Inhibitors and interleukin inhibitors. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on product type for each region.

Chapter 04 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Distribution Channel

Based on distribution channel, the psoriatic arthritis (PsA) treatment market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on distribution channel for each region.

Chapter 05 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Route of Administration

Based on route of administration, the psoriatic arthritis (PsA) treatment market is segmented into oral and injectable. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on route of administration in each region.

Chapter 06 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Region

This chapter explains how the psoriatic arthritis (PsA) treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

Chapter 07 – North America Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the North America psoriatic arthritis (PsA) treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, route of administration, distribution channel, and country in the psoriatic arthritis (PsA) treatment market of North America.

Chapter 08 – Latin America Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Readers can find detailed information about factors such as regional trends that are impacting the growth of the Latin America psoriatic arthritis (PsA) treatment market. This chapter also includes the growth prospects of the psoriatic arthritis (PsA) treatment market in leading LATAM countries such as Mexico, Brazil, and the rest of the Latin American region.

Chapter 09 – Europe Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Important growth prospects of the psoriatic arthritis (PsA) treatment market based on its product type, distribution channel, and route of administration in several countries such as the U.K., Germany, Spain, Italy, France, Russia, and the rest of Europe are included in this chapter.

Chapter 10 – APAC Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Japan, India, China, Australia, and the rest of APAC are the leading countries in the APAC region that are the prime subject of assessment to obtain the growth prospects of the APEC psoriatic arthritis (PsA) treatment market, in this chapter. Readers can find thorough information about the growth parameters of the APAC psoriatic arthritis (PsA) treatment market during the period 2018-2028.

Chapter 11 – MEA Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

This chapter provides information on how the psoriatic arthritis (PsA) treatment market will grow in major countries in the MEA region, such as GCC countries, South Africa, and the rest of MEA, during the period 2018-2028.

Chapter 12 – Competition Landscape, Company Share, and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the psoriatic arthritis (PsA) treatment market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The market players that have been featured in the report include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, UCB S.A., Eli Lilly & Co, Novartis AG, Celgene Corporation, and AstraZeneca PLC, among others.

Chapter 13 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 14 – Research Methodology

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the psoriatic arthritis (PsA) treatment market.

Psoriatic Arthritis Psa Treatment Market